VALIDATED EXECUTIVE ENGAGEMENTS
OUTREACH
759
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
152
Interactions with Platform & by Email
PARTICIPANTS
32
Unique # Participated
VALIDATIONS
14
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEP 2020
TABLES
105
PAGES
173
EDITION
9
PRICE
USD $4950
The U.S. Economy is Reinventing Itself to Weather Economic Storms.
Here's An Analytical Window into the Changing Opportunities.
Amid the COVID-19 crisis, the global market for Benign Prostatic Hyperplasia Devices estimated at US$362 Million in the year 2020, is projected to reach a revised size of US$500.3 Million by 2027, growing at a CAGR of 4.7% over the analysis period 2020-2027. TURP, one of the segments analyzed in the report, is projected to record a 4.7% CAGR and reach US$241.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Laser Therapy segment is readjusted to a revised 4.9% CAGR for the next 7-year period.
The Benign Prostatic Hyperplasia Devices market in the U.S. is estimated at US$106.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$88.8 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.
In the global Other Procedures segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$44.3 Million in the year 2020 will reach a projected size of US$60.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$55.9 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 173-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Boston Scientific Corporation; Karl Storz GmbH & Co. KG; Lumenis Ltd.; Olympus Corporation; Teleflex Inc.; Urologix, Inc.
» End-Use (Hospitals, ASCs, Urology Clinics) » Procedure (TURP, Laser Therapy, Other Procedures)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Benign Prostatic Hyperplasia Devices Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Benign Prostatic Hyperplasia Devices Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Benign Prostatic Hyperplasia Devices Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019 |
| Benign Prostatic Hyperplasia Devices Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| TURP (Procedure) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| TURP (Procedure) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019 |
| TURP (Procedure) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Laser Therapy (Procedure) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 |
| Laser Therapy (Procedure) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019 |
| Laser Therapy (Procedure) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Other Procedures (Procedure) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 |
| Other Procedures (Procedure) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019 |
| Other Procedures (Procedure) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Hospitals (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027 |
| Hospitals (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019 |
| Hospitals (End-Use) Share Breakdown Review by Region/Country: 2012 VS 2020 VS 2027 |
| ASCs (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| ASCs (End-Use) Global Historic Analysis in US$ Thousand by Region/Country: 2012-2019 |
| ASCs (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Urology Clinics (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027 |
| Urology Clinics (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019 |
| Urology Clinics (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Benign Prostatic Hyperplasia Devices Market Share (in %) by Company: 2019 & 2025 |
| United States Benign Prostatic Hyperplasia Devices Market Estimates and Projections in US$ Thousand by Procedure: 2020 to 2027 |
| Benign Prostatic Hyperplasia Devices Market in the United States by Procedure: A Historic Review in US$ Thousand for 2012-2019 |
| United States Benign Prostatic Hyperplasia Devices Market Share Breakdown by Procedure: 2012 VS 2020 VS 2027 |
| United States Benign Prostatic Hyperplasia Devices Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027 |
| Benign Prostatic Hyperplasia Devices Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019 |
| Benign Prostatic Hyperplasia Devices Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027 |
| CANADA |
| Canadian Benign Prostatic Hyperplasia Devices Market Estimates and Forecasts in US$ Thousand by Procedure: 2020 to 2027 |
| Canadian Benign Prostatic Hyperplasia Devices Historic Market Review by Procedure in US$ Thousand: 2012-2019 |
| Benign Prostatic Hyperplasia Devices Market in Canada: Percentage Share Breakdown of Sales by Procedure for 2012, 2020, and 2027 |
| Canadian Benign Prostatic Hyperplasia Devices Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 |
| Benign Prostatic Hyperplasia Devices Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019 |
| Canadian Benign Prostatic Hyperplasia Devices Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| JAPAN |
| Japanese Market for Benign Prostatic Hyperplasia Devices: Annual Sales Estimates and Projections in US$ Thousand by Procedure for the Period 2020-2027 |
| Benign Prostatic Hyperplasia Devices Market in Japan: Historic Sales Analysis in US$ Thousand by Procedure for the Period 2012-2019 |
| Japanese Benign Prostatic Hyperplasia Devices Market Share Analysis by Procedure: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Benign Prostatic Hyperplasia Devices in US$ Thousand by End-Use: 2020 to 2027 |
| Japanese Benign Prostatic Hyperplasia Devices Market in US$ Thousand by End-Use: 2012-2019 |
| Benign Prostatic Hyperplasia Devices Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 |
| CHINA |
| Chinese Benign Prostatic Hyperplasia Devices Market Growth Prospects in US$ Thousand by Procedure for the Period 2020-2027 |
| Benign Prostatic Hyperplasia Devices Historic Market Analysis in China in US$ Thousand by Procedure: 2012-2019 |
| Chinese Benign Prostatic Hyperplasia Devices Market by Procedure: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Demand for Benign Prostatic Hyperplasia Devices in US$ Thousand by End-Use: 2020 to 2027 |
| Benign Prostatic Hyperplasia Devices Market Review in China in US$ Thousand by End-Use: 2012-2019 |
| Chinese Benign Prostatic Hyperplasia Devices Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European Benign Prostatic Hyperplasia Devices Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Benign Prostatic Hyperplasia Devices Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027 |
| Benign Prostatic Hyperplasia Devices Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019 |
| European Benign Prostatic Hyperplasia Devices Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Benign Prostatic Hyperplasia Devices Market Estimates and Forecasts in US$ Thousand by Procedure: 2020-2027 |
| Benign Prostatic Hyperplasia Devices Market in Europe in US$ Thousand by Procedure: A Historic Review for the Period 2012-2019 |
| European Benign Prostatic Hyperplasia Devices Market Share Breakdown by Procedure: 2012 VS 2020 VS 2027 |
| European Benign Prostatic Hyperplasia Devices Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 |
| Benign Prostatic Hyperplasia Devices Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019 |
| European Benign Prostatic Hyperplasia Devices Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| FRANCE |
| Benign Prostatic Hyperplasia Devices Market in France by Procedure: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| French Benign Prostatic Hyperplasia Devices Historic Market Scenario in US$ Thousand by Procedure: 2012-2019 |
| French Benign Prostatic Hyperplasia Devices Market Share Analysis by Procedure: 2012 VS 2020 VS 2027 |
| Benign Prostatic Hyperplasia Devices Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027 |
| French Benign Prostatic Hyperplasia Devices Historic Market Review in US$ Thousand by End-Use: 2012-2019 |
| French Benign Prostatic Hyperplasia Devices Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| GERMANY |
| Benign Prostatic Hyperplasia Devices Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Procedure for the Period 2020-2027 |
| German Benign Prostatic Hyperplasia Devices Historic Market Analysis in US$ Thousand by Procedure: 2012-2019 |
| German Benign Prostatic Hyperplasia Devices Market Share Breakdown by Procedure: 2012 VS 2020 VS 2027 |
| Benign Prostatic Hyperplasia Devices Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027 |
| German Benign Prostatic Hyperplasia Devices Market in Retrospect in US$ Thousand by End-Use: 2012-2019 |
| Benign Prostatic Hyperplasia Devices Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027 |
| ITALY |
| Italian Benign Prostatic Hyperplasia Devices Market Growth Prospects in US$ Thousand by Procedure for the Period 2020-2027 |
| Benign Prostatic Hyperplasia Devices Historic Market Analysis in Italy in US$ Thousand by Procedure: 2012-2019 |
| Italian Benign Prostatic Hyperplasia Devices Market by Procedure: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Demand for Benign Prostatic Hyperplasia Devices in US$ Thousand by End-Use: 2020 to 2027 |
| Benign Prostatic Hyperplasia Devices Market Review in Italy in US$ Thousand by End-Use: 2012-2019 |
| Italian Benign Prostatic Hyperplasia Devices Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Benign Prostatic Hyperplasia Devices: Annual Sales Estimates and Projections in US$ Thousand by Procedure for the Period 2020-2027 |
| Benign Prostatic Hyperplasia Devices Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Procedure for the Period 2012-2019 |
| United Kingdom Benign Prostatic Hyperplasia Devices Market Share Analysis by Procedure: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Benign Prostatic Hyperplasia Devices in US$ Thousand by End-Use: 2020 to 2027 |
| United Kingdom Benign Prostatic Hyperplasia Devices Market in US$ Thousand by End-Use: 2012-2019 |
| Benign Prostatic Hyperplasia Devices Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Benign Prostatic Hyperplasia Devices Market Estimates and Forecasts in US$ Thousand by Procedure: 2020-2027 |
| Benign Prostatic Hyperplasia Devices Market in Rest of Europe in US$ Thousand by Procedure: A Historic Review for the Period 2012-2019 |
| Rest of Europe Benign Prostatic Hyperplasia Devices Market Share Breakdown by Procedure: 2012 VS 2020 VS 2027 |
| Rest of Europe Benign Prostatic Hyperplasia Devices Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 |
| Benign Prostatic Hyperplasia Devices Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019 |
| Rest of Europe Benign Prostatic Hyperplasia Devices Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Benign Prostatic Hyperplasia Devices Market in Asia-Pacific by Procedure: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| Asia-Pacific Benign Prostatic Hyperplasia Devices Historic Market Scenario in US$ Thousand by Procedure: 2012-2019 |
| Asia-Pacific Benign Prostatic Hyperplasia Devices Market Share Analysis by Procedure: 2012 VS 2020 VS 2027 |
| Benign Prostatic Hyperplasia Devices Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027 |
| Asia-Pacific Benign Prostatic Hyperplasia Devices Historic Market Review in US$ Thousand by End-Use: 2012-2019 |
| Asia-Pacific Benign Prostatic Hyperplasia Devices Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| REST OF WORLD |
| Rest of World Benign Prostatic Hyperplasia Devices Market Estimates and Forecasts in US$ Thousand by Procedure: 2020 to 2027 |
| Rest of World Benign Prostatic Hyperplasia Devices Historic Market Review by Procedure in US$ Thousand: 2012-2019 |
| Benign Prostatic Hyperplasia Devices Market in Rest of World: Percentage Share Breakdown of Sales by Procedure for 2012, 2020, and 2027 |
| Rest of World Benign Prostatic Hyperplasia Devices Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 |
| Benign Prostatic Hyperplasia Devices Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019 |
| Rest of World Benign Prostatic Hyperplasia Devices Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 38 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com